Where would we be without warfarin? The good old rat poison has served us brilliantly for decades, allowing us to anticoagulate patients to treat and prevent venous thromboembolism, prevent stroke […]
Get the NOAC Knowhow: Novel Oral Anticoagulants Part 1 Read More »
Appraisal and reflections on the recently published ConSEPT and EcLiPSE trials – what do they mean for the treatment of paediatric status epilepticus?
JC: Enter Sandman – Which Agent as Second Line in Paediatric Status Epilepticus? Read More »
So, this was the lecture title I was given for the RCEM CPD conference this year for the geriatric medicine session. Quite the opposite of what I usually talk about,
Complications of anticoagulation and how to manage them. St Emlyn’s Read More »
123We are in a new age of anticoagulation, Warfarin is becoming a drug of the past. To the benefit of our patients we are no longer dragging them into hospital
JC: Reversal of DOACs with Andexanet Alfa. St.Emlyn’s Read More »
Use of glue cyanoacrylate to secure peripheral intravenous cannula. St.Emlyn’s. randomised controlled trial critical appraisal.
JC: Should we glue cannulas to patients? St.Emlyn’s Read More »
What’s your weapon of choice then??? There have been a lot of developments within the last 10 years regarding our clinical approach to the patient with suspected pulmonary embolism.
Ambulatory PE: A walk in the park? St.Emlyn’s Read More »
A new study in the BMJ this week suggests benefit from use of the new oral anticoagulants. This is of significance to those of us in UK emergency medicine involved in
The new oral anticoagulants – the good news – or is it? Read More »
So, we’ve already talked about this. But changing times call for changing posts. And we want to know what you think… A 30 year old comes in 10 days after
The POP, the Chief, his risk assessment and her thromboprophylaxis Read More »
